About Summit:
Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.
Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:
Non-small Cell Lung Cancer (NSCLC)
HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.
Colorectal Cancer (CRC)
HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.
Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.
Job Title: Associate Director, Field Sales Training
Department: Commercial Operations
Location : Princeton, NJ
ASSOCIATE DIRECTOR, FIELD SALES TRAINING
Overview of Role:
The Associate Director, Field Sales Training will play a key role in building and delivering learning solutions that prepare the field sales organization to execute with confidence, consistency, and compliance. This individual will partner closely with Sales, Marketing, Market Access, Medical Affairs, Compliance, and external partners to develop training programs aligned to business priorities and field capability goals. The role requires deep understanding of oncology commercial environments, including the clinical, reimbursement, and access dynamics specific to intravenous, buy-and-bill oncology products
Role and Responsibilities:
Lead the design, development, and delivery of field sales training programs, including onboarding, product training, business acumen, selling skills, and ongoing capability development
Partner cross-functionally with Sales, Marketing, Market Access, Medical Affairs, Compliance, and external vendors to ensure training content is accurate, relevant, compliant, and aligned to business priorities
Translate commercial strategy into practical learning solutions that build field readiness and support effective execution
Partner with Sales Leadership to support training pull-through, coaching reinforcement, and field execution
Evaluate training effectiveness through assessments, stakeholder feedback, performance insights, and defined learning metrics
Leverage modern learning methodologies, technology platforms, and AI-enabled tools to enhance learner engagement, accessibility, and pull-through
Develop training content specific to oncology practice environments, including infusion center access, biomarker testing and result interpretation, and buy-and-bill reimbursement processes
Maintain current knowledge of oncology, market dynamics, adult learning principles, and industry best practices
Demonstrate the highest standards…